| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-06 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-06 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-06 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-05 |
| mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
7e-05 |
| mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |